These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2004-004340-42||An Open Label, Randomized, Phase I/II Study of DMXAA in Combination with Carboplatin and Paclitaxel in Patients with Locally Advanced and Metastatic Non-Small Cell Lung Cancer.||2007-07-18||due-trials|
|Listed as ongoing, but also has a completion date||2004-004375-11||AN OPEN LABEL, RANDOMISED, PHASE II STUDY OF AS1404 IN COMBINATION WITH CARBOPLATIN AND PACLITAXEL IN PATIENTS WITH PLATINUM-SENSITIVE RECURRENT OVARIAN EPITHELIAL CANCER||2008-05-16||bad-data|
|Listed as ongoing, but also has a completion date||2007-004427-38||Estudio abierto y aleatorizado en fase 3 de L-malato de amonafida en combinación con citarabina comparado con daunorrubicina en combinación con citarabina en pacientes con leucemia mieloide aguda (LMA...||2011-01-31||bad-data|
|Listed as ongoing, but also has a completion date||2008-001806-17||A Phase II, Randomised, Open-Label, Multicentre Study of AS1402 in Combination with Letrozole as First Line Treatment in Postmenopausal Women with Locally Advanced or Metastatic Breast Cancer.||2009-08-07||bad-data|